{"title":"秋水仙提取物和紫杉醇对c - 4i和Vero细胞的抗增殖作用","authors":"O. D. Ozsoylemez, G. Ozcan","doi":"10.26650/eurjbiol.2018.0016","DOIUrl":null,"url":null,"abstract":"DOI: 10.26650/EurJBiol.2018.0016 Objective: This study was conducted to determine the antiproliferative effects of paclitaxel (PAC) and Colchicum umbrosum plant extract on C-4 I and Vero cells. In addition, the apoptotic effects of plant extract on these cells were compared. Materials and Methods: C-4 I and Vero cells were treated with PAC and corm extract of C. umbrosum for 24 h. The antiproliferative effects of 0.01, 0.1, and 1 mg/mL of plant extract and 7.5, 15, and 30 nM of PAC and the half maximal inhibitory concentration (IC50) values were determined by the MTT method. Morphological changes occurring in the C-4 I and Vero cells were observed under phase-contrast and fluorescence microscopes using DAPI staining. Results: The IC50 values were found to be 0.01 mg/mL in C-4 I cells and 1 mg/mL in Vero cells for the plant extract and 15 nM in C-4 I and Vero cells for PAC. The apoptotic index (AI) values of the experimental groups of C-4 I and Vero cells were significantly increased compared to those of the control group (p<0.01) after treatment with IC50 concentration of the plant extract. The AI values of the plant extract treatment in C-4 I cells were higher than those in Vero cells at 24 and 48 h. Conclusion: Treatment with the IC50 concentration of the plant extract induced apoptotic cell death in C-4 I cells. It can worth be considered as a novel promising candidate for the treatment of cancer.","PeriodicalId":9711,"journal":{"name":"Central European Journal of Biology","volume":"01 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Antiproliferative Activity of Colchicum umbrosum Plant Extract and Paclitaxel on C-4 I and Vero Cells\",\"authors\":\"O. D. Ozsoylemez, G. Ozcan\",\"doi\":\"10.26650/eurjbiol.2018.0016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"DOI: 10.26650/EurJBiol.2018.0016 Objective: This study was conducted to determine the antiproliferative effects of paclitaxel (PAC) and Colchicum umbrosum plant extract on C-4 I and Vero cells. In addition, the apoptotic effects of plant extract on these cells were compared. Materials and Methods: C-4 I and Vero cells were treated with PAC and corm extract of C. umbrosum for 24 h. The antiproliferative effects of 0.01, 0.1, and 1 mg/mL of plant extract and 7.5, 15, and 30 nM of PAC and the half maximal inhibitory concentration (IC50) values were determined by the MTT method. Morphological changes occurring in the C-4 I and Vero cells were observed under phase-contrast and fluorescence microscopes using DAPI staining. Results: The IC50 values were found to be 0.01 mg/mL in C-4 I cells and 1 mg/mL in Vero cells for the plant extract and 15 nM in C-4 I and Vero cells for PAC. The apoptotic index (AI) values of the experimental groups of C-4 I and Vero cells were significantly increased compared to those of the control group (p<0.01) after treatment with IC50 concentration of the plant extract. The AI values of the plant extract treatment in C-4 I cells were higher than those in Vero cells at 24 and 48 h. Conclusion: Treatment with the IC50 concentration of the plant extract induced apoptotic cell death in C-4 I cells. It can worth be considered as a novel promising candidate for the treatment of cancer.\",\"PeriodicalId\":9711,\"journal\":{\"name\":\"Central European Journal of Biology\",\"volume\":\"01 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Central European Journal of Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26650/eurjbiol.2018.0016\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Central European Journal of Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26650/eurjbiol.2018.0016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Antiproliferative Activity of Colchicum umbrosum Plant Extract and Paclitaxel on C-4 I and Vero Cells
DOI: 10.26650/EurJBiol.2018.0016 Objective: This study was conducted to determine the antiproliferative effects of paclitaxel (PAC) and Colchicum umbrosum plant extract on C-4 I and Vero cells. In addition, the apoptotic effects of plant extract on these cells were compared. Materials and Methods: C-4 I and Vero cells were treated with PAC and corm extract of C. umbrosum for 24 h. The antiproliferative effects of 0.01, 0.1, and 1 mg/mL of plant extract and 7.5, 15, and 30 nM of PAC and the half maximal inhibitory concentration (IC50) values were determined by the MTT method. Morphological changes occurring in the C-4 I and Vero cells were observed under phase-contrast and fluorescence microscopes using DAPI staining. Results: The IC50 values were found to be 0.01 mg/mL in C-4 I cells and 1 mg/mL in Vero cells for the plant extract and 15 nM in C-4 I and Vero cells for PAC. The apoptotic index (AI) values of the experimental groups of C-4 I and Vero cells were significantly increased compared to those of the control group (p<0.01) after treatment with IC50 concentration of the plant extract. The AI values of the plant extract treatment in C-4 I cells were higher than those in Vero cells at 24 and 48 h. Conclusion: Treatment with the IC50 concentration of the plant extract induced apoptotic cell death in C-4 I cells. It can worth be considered as a novel promising candidate for the treatment of cancer.